tag:blogger.com,1999:blog-21888150.post114084274131595160..comments2023-07-21T22:14:54.925+10:00Comments on CoreEcon: Commentary on economics, strategy and more: How about some premium insurance?Joshua Ganshttp://www.blogger.com/profile/13713171032343855718noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-21888150.post-1143508787723166682006-03-28T12:19:00.000+11:002006-03-28T12:19:00.000+11:00So many difficulties arise from this game of music...So many difficulties arise from this game of musical chairs between providers, insurers, patients and device and drug companies. As many of the cost increases faced by insurers are due to price increases for drugs and devices, how much of this problem could be addressed by: <BR/>a)different approaches to fund reimbursement levels; and/or <BR/>b)adjustments to the intellectual property laws (with Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-21888150.post-1141207961117259832006-03-01T21:12:00.000+11:002006-03-01T21:12:00.000+11:00subsidise private hospitals and medical expenses d...<I> subsidise private hospitals and medical expenses directly based on the same cost benchmarks as the public system.</I><BR/><BR/>Why subsidise the private system when the public system can do it cheaper both at the margins and at the average cost?<BR/><BR/>The public system has offered the private system the public cost units (casemix)for ages. No one will take it up. Why?FXHhttps://www.blogger.com/profile/14927037961123914689noreply@blogger.com